Bio
Tridu Huynh, MD is a Clinical Assistant Professor in the Department of Medicine, Division of Hospital Medicine. He received his Bachelor of Science with a major in Molecular, Cell and Developmental Biology and minor in Biomedical Research at the University of California - Los Angeles. He then investigated the role of nuclear receptor nur77 in CD8 T-cells' function at the La Jolla Institute for Immunology prior to attending the University of Vermont - College of Medicine, where he received his MD. He subsequently completed a KL2-funded ABIM physician-scientist pathway in Internal Medicine with an immuno-oncology research focus at The Scripps Clinic and The Scripps Research Institute, where he studied novel immunotherapy combinations with a focus on tumor-infiltrating T-cells and natural killer cells in a patient-derived xenograft of human lung cancer, as well as the impact of SARS-CoV-2 immunologically. Thereafter, he pursued a Hematology/Oncology fellowship at the University of California - San Diego, where he designed two clinical trials in lung cancer and Kaposi sarcoma. He has published in several journals including the Journal of Clinical Investigation, Journal for Immunotherapy of Cancer, Journal of Immunology, and Nature Scientific Reports. Dr. Huynh now practices clinically as a hospitalist with a continued research interest in translational immunology/molecular biology leveraging machine-learning capabilities.
